MarjoryCharlotMD

Oncology • Chapel Hill, NC

Thoracic Cancer

Assistant Professor, Medicine, University of North Carolina

Join to view full profile

Dr. Charlot is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Charlot's full profile

Already have an account?

Office
170 Manning Drive
HEMATOLOGY/ONCOLOGY
Chapel Hill, NC 27599
Phone+1 919-445-2545

Fax+1 919-966-6735

Education & Training

Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Boston University Medical CenterResidency, Internal Medicine, 2004 - 2007
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2004

Certifications & Licensure

NC State Medical License 2018 - 2025
MA State Medical License 2006 - 2019
American Board of Internal Medicine Medical Oncology

Clinical Trials

Mindfulness Based Smoking Cessation Program Start of enrollment: 2016 Jul 01
Completed
Not Applicable

Publications & Presentations

PubMed

Scoping Review of Barriers and Facilitators to Recruitment of Black People With Cancer in Biospecimen-Based Research.
Hayley N Morris, Ashlee Taylor Winslow, Jeenn Alain Barreiro-Rosado, Stacy Torian, Marjory Charlot
JCO Precision Oncology. 2024-05-01
Delivery of Novel Therapies without Ensuring Equitable Access - Are Cancer Centers Putting the CART19 before the Horse?
Marjory Charlot, Giselle Corbie
NEJM Evidence. 2024-04-01
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, Melina E Marmarelis, Carolyn J Presley
Lung Cancer. 2023-12-01

Press Mentions

Rashid Awarded Grant to Develop AI Tool That Recommends Optimal Clinical Trials to Pancreatic Cancer PatientsSeptember 24th, 2024
Modest Population-Level Increases in Survival Observed After Implementation of Immune Checkpoint Inhibitors in the Treatment of Advanced NSCLC, Particularly Among the Older PatientsFebruary 1st, 2023
Intervention Reduces Disparities in Timing of Lung Cancer Surgery Between Black and White PatientsFebruary 14th, 2022
Join now to see all